1-2 of 2
Marten Heeringa
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Co-Administration of YM150, An Oral Direct Factor Xa Inhibitor, and Naproxen Does Not Result In Clinically Relevant Changes to the Pharmacodynamic or Pharmacokinetic Profile of Either Agent

Marten Heeringa, Alberto Garcia-Hernandez, Takeshi Kadokura, Dorien Groenendaal – van de Meent, Gregory Strabach, Roelof Mol, Charlotte Eltink, Hartmut Heinzerling
Journal: Blood
Blood (2010) 116 (21): 4393.
https://doi.org/10.1182/blood.V116.21.4393.4393
Published: 2010
Journal Articles

YM150, An Oral Direct Inhibitor of Factor Xa, Demonstrated a Predictable and Dose-Proportional Pharmacokinetic/Pharmacodynamic Profile After Single and Multiple Dosing: Results From Three Studies

Dorien Groenendaal– van de Meent, Marten Heeringa, Takeshi Kadokura, Frank Verheggen, Gregory Strabach, Hartmut Heinzerling
Journal: Blood
Blood (2010) 116 (21): 3323.
https://doi.org/10.1182/blood.V116.21.3323.3323
Published: 2010